LND topic: tme page 202

Chronic migraines are a real pain, literally. They can last for weeks or even months. People who suffer from them often try different treatments to find relief. One study looked at combining two treatments: atogepant and onabotulinumtoxinA. The goal was to see if this combo could help control chroni

education

When Progress Stalls: Kids' Disability Rights in Limbo

Parents like Christine Smith Olsey faced a tough time when they tried to get help for their kids with disabilities. Olsey's son was struggling in school, and she knew something wasn't right. She asked for extra help, but the school didn't listen. So, she filed a complaint with the state and then wit

politics

Wrestling with Education

A Senate panel has sent Linda McMahon's nomination for Education secretary to the full Senate for a vote. This move comes despite concerns about President Trump's past remarks about shutting down the Education Department. McMahon, who co-founded and led the WWE with her husband Vince, is known for

Brain Drain: How Doctors Feel Appreciated in the Neurology World

In the world of medicine, especially in neurology, it's crucial to understand how doctors and trainees feel about their work environment. A recent study focused on this, looking at how different ways of showing appreciation are seen by faculty and trainees in a neurology department at a big academic

Unlocking Lung Cancer Secrets: KRAS Mutations and Treatment

Lung cancer is a tricky disease, and one type, non-small cell lung cancer (NSCLC), can be even trickier. Why? Because it can have different mutations, and these mutations can affect how well treatments work. Two of these mutations are called KRAS G12C and KRAS G12D. They are not the same and can beh

Migraines: A Hidden Epidemic

Migraines are a big deal, affecting around 14. 4% of people worldwide. This means nearly one in seven individuals is dealing with this painful condition. The goal was to understand who gets migraines and how it impacts their healthcare needs. First, let's talk about the numbers. Migraines are more

finance

Palantir: A Tech Titan on the Rise

Palantir, a software giant, is making waves in the artificial intelligence (AI) market. Loop Capital, a financial firm, has given it a thumbs-up with a buy rating and a price target of $141. This means they think the stock could jump by more than 25% from its current price. The firm believes Palanti

science

Gold Nanoparticles: A New Hope for Alzheimer's Treatment?

Alzheimer's disease is a tough opponent, but scientists are finding new ways to fight it. Gold nanoparticles, tiny particles made of gold, are proving to be a powerful tool in the battle against this neurodegenerative disease. These nanoparticles can be loaded with afzelin, a natural compound found

Rituximab and COVID-19: A Real-World Test for Tixagevimab-Cilgavimab

People with rheumatic diseases often take rituximab, a medicine that can make them more likely to catch COVID-19. Doctors wanted to see if a new treatment, tixagevimab-cilgavimab, could help. This combo was tested on patients already taking rituximab. The goal was to find out if it could stop COVID-

politics

Trump's Speech at Saudi-Backed Event Raises Eyebrows